Roger Von Moos
AuthID: R-00F-FA9
1
TITLE: Management of bone health in solid tumours: From bisphosphonates to a monoclonal antibody Full Text
AUTHORS: Roger von Moos; Luis Costa; Eva Gonzalez Suarez; Evangelos Terpos; Daniela Niepel; Jean Jacques Body;
PUBLISHED: 2019, SOURCE: CANCER TREATMENT REVIEWS, VOLUME: 76
AUTHORS: Roger von Moos; Luis Costa; Eva Gonzalez Suarez; Evangelos Terpos; Daniela Niepel; Jean Jacques Body;
PUBLISHED: 2019, SOURCE: CANCER TREATMENT REVIEWS, VOLUME: 76
INDEXED IN: 
Scopus 
WOS
Scopus WOS2
TITLE: Healthcare-resource utilization associated with radiation to bone across eight European countries: Results from a retrospective study Full Text
AUTHORS: Roger von Moos; Jean Jacques Body; Oliver Guenther; Evangelos Terpos; Yves Pascal Acklin; Jindrich Finek; Joao Pereira; Nikos Maniadakis; Guy Hechmati; Susan Talbot; Harm Sleeboom;
PUBLISHED: 2018, SOURCE: JOURNAL OF BONE ONCOLOGY, VOLUME: 10
AUTHORS: Roger von Moos; Jean Jacques Body; Oliver Guenther; Evangelos Terpos; Yves Pascal Acklin; Jindrich Finek; Joao Pereira; Nikos Maniadakis; Guy Hechmati; Susan Talbot; Harm Sleeboom;
PUBLISHED: 2018, SOURCE: JOURNAL OF BONE ONCOLOGY, VOLUME: 10
INDEXED IN: Scopus WOS
Scopus WOS3
TITLE: Improving quality of life in patients with advanced cancer: Targeting metastatic bone pain Full Text
AUTHORS: Roger von Moos; Luis Costa; Carla Ida Ripamonti; Daniela Niepel; Daniele Santini;
PUBLISHED: 2017, SOURCE: EUROPEAN JOURNAL OF CANCER, VOLUME: 71
AUTHORS: Roger von Moos; Luis Costa; Carla Ida Ripamonti; Daniela Niepel; Daniele Santini;
PUBLISHED: 2017, SOURCE: EUROPEAN JOURNAL OF CANCER, VOLUME: 71
INDEXED IN: WOS
WOS4
TITLE: Delaying skeletal-related events in a randomized phase 3 study of denosumab versus zoledronic acid in patients with advanced cancer: an analysis of data from patients with solid tumors Full Text
AUTHORS: David Henry; Saroj Vadhan Raj; Vera Hirsh; Roger von Moos; Vania Hungria; Luis Costa; Penella J Woll; Giorgio Scagliotti; Geoffrey Smith; Amy Feng; Susie Jun; Roger Dansey; Howard Yeh;
PUBLISHED: 2014, SOURCE: SUPPORTIVE CARE IN CANCER, VOLUME: 22, ISSUE: 3
AUTHORS: David Henry; Saroj Vadhan Raj; Vera Hirsh; Roger von Moos; Vania Hungria; Luis Costa; Penella J Woll; Giorgio Scagliotti; Geoffrey Smith; Amy Feng; Susie Jun; Roger Dansey; Howard Yeh;
PUBLISHED: 2014, SOURCE: SUPPORTIVE CARE IN CANCER, VOLUME: 22, ISSUE: 3
5
TITLE: Skeletal-related events in patients with solid tumors receiving denosumab or zoledronic acid by baseline pain status: Results from three phase 3 trials Full Text
AUTHORS: Von Moos, R; Stopeck, A; Fizazi, K; Cleeland, C; Brown, JE; Oudard, S; Costa, L; Wang, H; Braun, A;
PUBLISHED: 2013, SOURCE: European Cancer Congress 2013 - 17th ECCO / 38th ESMO / 32nd ESTRO in EUROPEAN JOURNAL OF CANCER, VOLUME: 49
AUTHORS: Von Moos, R; Stopeck, A; Fizazi, K; Cleeland, C; Brown, JE; Oudard, S; Costa, L; Wang, H; Braun, A;
PUBLISHED: 2013, SOURCE: European Cancer Congress 2013 - 17th ECCO / 38th ESMO / 32nd ESTRO in EUROPEAN JOURNAL OF CANCER, VOLUME: 49
INDEXED IN: WOS
WOS6
TITLE: Efficacy and safety of bevacizumab in combination with docetaxel for the first-line treatment of elderly patients with locally recurrent or metastatic breast cancer: Results from AVADO Full Text
AUTHORS: Xavier Pivot; Andreas Schneeweiss; Shailendra Verma; Christoph Thomssen; Jose Luis Passos Coelho; Giovanni Benedetti; Eva Ciruelos; Roger von Moos; Hong Tai Chang; Anja Alexandra Duenne; David W Miles;
PUBLISHED: 2011, SOURCE: EUROPEAN JOURNAL OF CANCER, VOLUME: 47, ISSUE: 16
AUTHORS: Xavier Pivot; Andreas Schneeweiss; Shailendra Verma; Christoph Thomssen; Jose Luis Passos Coelho; Giovanni Benedetti; Eva Ciruelos; Roger von Moos; Hong Tai Chang; Anja Alexandra Duenne; David W Miles;
PUBLISHED: 2011, SOURCE: EUROPEAN JOURNAL OF CANCER, VOLUME: 47, ISSUE: 16
7
TITLE: Ras Inhibition and the Survival Benefit Favoring Zoledronic Acid Compared With Denosumab in Patients With Multiple Myeloma Reply
AUTHORS: David H Henry; Luis Costa; Francois Goldwasser; Vera Hirsh; Vania Hungria; Jana Prausova; Giorgio Vittorio Scagliotti; Harm Sleeboom; Andrew Spencer; Saroj Vadhan Raj; Roger von Moos; Wolfgang Willenbacher; Jianming M Wang; Qi Jiang; Susie Jun; Roger Dansey; Howard Yeh;
PUBLISHED: 2011, SOURCE: JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 29, ISSUE: 19
AUTHORS: David H Henry; Luis Costa; Francois Goldwasser; Vera Hirsh; Vania Hungria; Jana Prausova; Giorgio Vittorio Scagliotti; Harm Sleeboom; Andrew Spencer; Saroj Vadhan Raj; Roger von Moos; Wolfgang Willenbacher; Jianming M Wang; Qi Jiang; Susie Jun; Roger Dansey; Howard Yeh;
PUBLISHED: 2011, SOURCE: JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 29, ISSUE: 19
INDEXED IN: Scopus WOS
Scopus WOS8
TITLE: Randomized, Double-Blind Study of Denosumab Versus Zoledronic Acid in the Treatment of Bone Metastases in Patients With Advanced Cancer (Excluding Breast and Prostate Cancer) or Multiple Myeloma
AUTHORS: David H Henry; Luis Costa ; Francois Goldwasser; Vera Hirsh; Vania Hungria; Jana Prausova; Giorgio Vittorio Scagliotti; Harm Sleeboom; Andrew Spencer; Saroj Vadhan Raj; Roger von Moos; Wolfgang Willenbacher; Penella J Woll; Jianming M Wang; Qi Jiang; Susie Jun; Roger Dansey; Howard Yeh;
PUBLISHED: 2011, SOURCE: JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 29, ISSUE: 9
AUTHORS: David H Henry; Luis Costa ; Francois Goldwasser; Vera Hirsh; Vania Hungria; Jana Prausova; Giorgio Vittorio Scagliotti; Harm Sleeboom; Andrew Spencer; Saroj Vadhan Raj; Roger von Moos; Wolfgang Willenbacher; Penella J Woll; Jianming M Wang; Qi Jiang; Susie Jun; Roger Dansey; Howard Yeh;
PUBLISHED: 2011, SOURCE: JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 29, ISSUE: 9
INDEXED IN: WOS 
CrossRef
WOS CrossRef